PTEN and breast neoplasm: To address the above questions, in the current study, we compared PTEN expression by IHC between pretreatment core biopsies and residual primary breast tumors and lymph node metastases after neoadjuvant chemotherapy in patients enrolled in a single-institution prospective TNBC trial.